Background: The burden of dementia is poorly understood in Nigeria. We sought to gather available epidemiologic evidence on dementia in Nigeria to provide country-wide estimates of its prevalence and associated risks.
Methods: We searched MEDLINE, EMBASE, Global Health, Africa Journals Online (AJOL) and Google Scholar for epidemiologic studies on dementia in Nigeria from 1990 to 2018. We pooled crude estimates using random effects meta-analysis. A meta-regression epidemiologic model, using the United Nations demographics for Nigeria, was used to estimate the absolute number of people living with dementia in Nigeria in 1995 and 2015.
Results: Our searches returned 835 studies, of which nine were selected. These included 10 820 individuals with a median age of 74.4 years. Heterogeneity ( =98.8%, <0.001) was high across studies. Five studies were conducted in the South-west, and four studies were rated as high quality. The pooled crude prevalence of dementia in Nigeria was 4.9% (95% CI: 3.0-6.9) with prevalence significantly higher in women (6.7%, 3.6-9.9) compared to men (3.1%, 1.2-5.0). Age 80+ (odds ratio (OR) 1.6, 1.3-1.9), female sex (OR 2.2, 1.4-3.4) and BMI ≤18.5 (OR 3.5, 1.2-10.1) were significant risks for dementia in Nigeria. Using our epidemiologic model, we estimated that the number of dementia cases increased by over 400% over a 20-year period, increasing from 63 512 in 1995 to 318 011 in 2015 among persons aged ≥60 years.
Conclusion: Our findings suggest the prevalence and cases of dementia have increased in Nigeria over the last two decades. Population-wide response to dementia is lacking.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746335 | PMC |
| http://dx.doi.org/10.29392/joghr.3.e2019014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1.
Nat Struct Mol Biol
December 2024
Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Recently, an African ancestry-specific Parkinson disease (PD) risk signal was identified at the gene encoding glucocerebrosidase (GBA1). This variant ( rs3115534 -G) is carried by ~50% of West African PD cases and imparts a dose-dependent increase in risk for disease. The risk variant has varied frequencies across African ancestry groups but is almost absent in European and Asian ancestry populations.
View Article and Find Full Text PDFSMART-PET: a Self-SiMilARiTy-aware generative adversarial framework for reconstructing low-count [18F]-FDG-PET brain imaging.
Front Nucl Med
November 2024
Multimodal Imaging of Neurodegenerative Diseases (MiND) Lab, Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Introduction: In Positron Emission Tomography (PET) imaging, the use of tracers increases radioactive exposure for longitudinal evaluations and in radiosensitive populations such as pediatrics. However, reducing injected PET activity potentially leads to an unfavorable compromise between radiation exposure and image quality, causing lower signal-to-noise ratios and degraded images. Deep learning-based denoising approaches can be employed to recover low count PET image signals: nonetheless, most of these methods rely on structural or anatomic guidance from magnetic resonance imaging (MRI) and fails to effectively preserve global spatial features in denoised PET images, without impacting signal-to-noise ratios.
View Article and Find Full Text PDFArticle Synopsis
- HIV significantly affects neurocognitive function in Africa, leading to high prevalence rates of neurocognitive disorders, with Central and South Africa showing the highest impairment levels (around 49.33%).
- Variability in neurocognitive impairment prevalence is influenced by factors like ART availability, healthcare infrastructure, and co-infections, emphasizing the need for targeted interventions.
- Addressing this issue requires collaboration among healthcare providers, policymakers, and communities, focusing on education, early detection, improved resources, and research partnerships to better support individuals living with HIV.
Ethical issues in genomics research in persons with Alzheimer's Disease/Alzheimer's Disease-related dementia (AD/ADRD): a systematic review.
BMC Med Ethics
November 2024
Center for Bioethics and Research, 102 Basorun Rd, Akobo, Ibadan, Oyo State, 200285, Nigeria.
Article Synopsis
- There is an increasing focus on ethical challenges in genomics research for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) due to the vulnerabilities of study participants.
- A systematic review of 5,509 papers narrowed down to 27 relevant studies, uncovering 109 ethical issues categorized under a framework addressing ethical principles specific to AD/ADRD research.
- The review highlights a lack of literature on critical ethical principles like "fair participant selection" and "social value," suggesting a need for more comprehensive research on these topics in various socioeconomic contexts.
Documenting the burden of dementia in Africa: new approaches and key lessons.
Lancet Glob Health
December 2024
University College Hospital, University of Ibadan, Ibadan 200212, Nigeria.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!